NexImmune Inc.
NexImmune Strengthens Scientific Leadership by Appointing Jerome Zeldis as EVP R&D and Jeffrey Weber as Chief Scientific Advisor
- Zeldis formerly served as Celgene CMO and CEO of Celgene Global Health
- Weber is a renowned melanoma specialist and leading immunotherapy translational and clinical scientist
- Both will help NexImmune advance current early-stage clinical trials and will guide Company’s translational efforts to develop new immunotherapy products
January 4, 2021